EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY-NC-ND 4.0

p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans

Hwang Chan Yu, Byeoung Hoon Chung iD, Yoejin Kim iD, Yoonji Lee iD, Hyunchae Sim iD, Sangkyu Lee, Hong Pil Hwang iD, Hee Chul Yu iD, Seunggyu Jeon, Han-Joo Maeng, Dongyun Shin iD, Kyung Pyo Kang iD und 3 weitere

Journal of the American Society of Nephrology · 2025-07 · 36 (7) · 1264-1277

DOI: 10.1681/asn.0000000649 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 28.02.2025. Verfasst von Hwang Chan Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejon, Republic of Korea. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bio & Medical Technology Development Program, Basic Science Research Program, Medical Scientist Training Program from the Ministry of Science & ICT of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points p21-activated kinase 4 (PAK4) phosphorylates and inactivates GSH peroxidase 3 in the kidney after ischemia-reperfusion. Mice lacking PAK4 or treated with PAK4 proteolysis-targeting chimera were protected from kidney damage caused by ischemia-reperfusion injury. PAK4 expression in kidney tissues post-transplant inversely correlated with kidney function.

Background

AKI after ischemia-reperfusion remains a substantial perioperative challenge lacking effective treatment. p21-activated kinase 4 (PAK4), a downstream effector of Rho GTPase, has been explored in hepatic ischemia-reperfusion injury, but its role in renal ischemia-reperfusion is unknown.

Methods

Wild-type and proximal tubule–specific Pak4 knockout mice underwent 25 minutes of ischemia followed by 24 hours of reperfusion injury. Primary tubular cells and human kidney-2 cells were exposed to hypoxia-reoxygenation injury to investigate the in vitro effect of PAK4. Selective degradation of PAK4 was employed using proteolysis-targeting chimera (PROTAC) to ameliorate AKI.

Results

Post–ischemia-reperfusion, the expression of PAK4 was upregulated through hypoxia-inducible factor 1 α in mouse kidneys. Deletion of PAK4 in proximal tubule cells, but not in myeloid cells, significantly mitigated ischemia-reperfusion–induced AKI, as evidenced by decreased levels of BUN, creatinine, tubular necrosis, apoptosis, macrophage infiltration, and lipid accumulation compared with control mice. Further investigation revealed that PAK4 phosphorylated GSH peroxidase 3 (GPx3) at T47, leading to its proteasomal degradation. In addition, pretreatment of mice with the PAK4 PROTAC preserved GPx3 and enhanced fatty acid β -oxidation, thereby protecting against AKI. In kidney tissues from people with a kidney transplant, elevated levels of PAK4 protein and phosphorylation of GPx3 at T47 were observed.

Conclusions

Renal tubular PAK4 contributes to tissue damage during ischemia-reperfusion injury, whereas PAK4 PROTAC mitigates ischemia-reperfusion injury by reducing oxidative stress and promoting fatty acid β -oxidation.

Schlagwörter

Stichwörter der Autor:innen

ischemia-reperfusionmetabolismoxidative stress

Autor:innen und Institutionen

  • Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejon, Republic of Korea.
  • Department of Surgery, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
  • College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
  • School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • College of Pharmacy, Gachon University, Incheon, Republic of Korea.
  • Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Republic of Korea.

ORCID-Profile: Byeoung Hoon Chung, Yoejin Kim, Yoonji Lee, Hyunchae Sim, Hong Pil Hwang, Hee Chul Yu, Dongyun Shin, Kyung Pyo Kang, Seung-Yong Seo, Eun Ju Bae, Byung-Hyun Park

Förderung

  • Bio & Medical Technology Development Program
  • Basic Science Research Program
  • Medical Scientist Training Program from the Ministry of Science & ICT of Korea
  • KAIST Jang Young Sil Fellow Program

Zitieren

APA

Yu, H. C., Chung, B. H., Kim, Y., Lee, Y., Sim, H., Lee, S., Hwang, H. P., Yu, H. C., Jeon, S., Maeng, H. J., Shin, D., Kang, K. P., Seo, S. Y., Bae, E. J., & Park, B. H. (2025). p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans. Journal of the American Society of Nephrology, 36(7), 1264-1277. https://doi.org/10.1681/asn.0000000649

Vancouver

Yu HC, Chung BH, Kim Y, Lee Y, Sim H, Lee S, et al. p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans. Journal of the American Society of Nephrology. 2025;36(7):1264-1277. doi:10.1681/asn.0000000649

BibTeX
@article{Yu2025,
  author = {Yu, Hwang Chan and Chung, Byeoung Hoon and Kim, Yoejin and Lee, Yoonji and Sim, Hyunchae and Lee, Sangkyu and Hwang, Hong Pil and Yu, Hee Chul and Jeon, Seunggyu and Maeng, Han-Joo and Shin, Dongyun and Kang, Kyung Pyo and Seo, Seung-Yong and Bae, Eun Ju and Park, Byung-Hyun},
  title = {p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans},
  journal = {Journal of the American Society of Nephrology},
  year = {2025},
  volume = {36},
  number = {7},
  pages = {1264--1277},
  doi = {10.1681/asn.0000000649}
}
Kostenlos starten →